buprenorphine-naloxoneopioid use disorder (OUD)status epilepticus
…(1) refractory pain, (2) palliative sedation, (3) initiation of buprenorphine-naloxone for cancer-associated pain in a patient with opioid use disorde…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 241–300 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Oestrogen13Sorafenib13AMIKACIN13Fluorouracil13Duloxetine13Pemetrexed13Norepinephrine13Sertraline13Guselkumab13Tamoxifen13diazepam13Vincristine13Lupus Anticoagulant13Puberty blockers13BEL12FIB-412Gentamicin12Clozapine12Sirolimus12Bempedoic acid12Erenumab12Galcanezumab12Gabapentinoids12Procalcitonin12Allopurinol12Sildenafil12Metamizole12abatacept12pyridostigmine12tremelimumab12Bictegravir12Nifedipine12Sodium-glucose cotransporter-2 inhibitors12Checkpoint inhibitors12Elexacaftor12Wegovy12vasopressors12GLP-1 RA11Tislelizumab11SELADELPAR11IFX11PBO11Voclosporin11ARNI11BCG11PD-L111DAPT11Simvastatin11Exenatide11Denosumab11Everolimus11trametinib11Cannabidiol11Digoxin11Omalizumab11Fluoxetine11LAMA11Mepivacaine11Benzodiazepine11Folic acid11
Articles mentioning drugs
10,506 articles · page 487 of 876HIV-PrEP
… 27.2%, respectively). Condom use was low across partner types. HIV-PrEP was always used by HIV-negative participants in two times as ma…
antibioticspaediatric Crohn’s diseaseIntra-abdominal abscessesentero-enteric fistulas
…s recurred in 20%.Of 12 children with EEF, 10/12 (83%) received antibiotics, 12/12 (100%) received nutritional support, and 1 (8.3%) requir…
metforminTurner syndrome
…d cardiac anomalies; 10/19 were receiving GH, 9/19 HRT and 3/19 metformin. Overall, 12/19 (63%) had abnormal liver function tests. Steato…
miglustatNiemann-Pick CCrohn’s diseaseAnti-TNF therapyUK metabolic centreinflammatory bowel diseaseanti-aTNF therapy
… interpretation of clinical progression. The GI side-effects of miglustat can be confused with presentation of IBD.Due to the rarity of N…
vedolizumabinfliximabIBDPaediatric inflammatory bowel diseaseinflammatory bowel diseasedisuse colitisUK tertiary referral centreIBDUeosinophilic colitisamebiasis
…(11%), with two commencing or escalating biologics (infliximab, vedolizumab) and one receiving a non-biologic adjustment. No surgical refer…
TeduglutideShort bowel syndromeSBS-IF
…r-related sepsis, and SBS is associated with growth impairment. Teduglutide, a glucagon-like peptide-2 (GLP-2) analogue, promotes intestina…
laxativesprokineticssmall bowel pathologytertiary paediatric centre
…rs prior to capsule ingestion with ample clear fluids given. No laxatives or prokinetics are used. Despite increasing use of VCE in child…
VisiumHDimmunotherapyHepatocellular carcinomaHCChepatocellular carcinoma (HCC)
…lants. A: overview of explant A, showing the region captured by VisiumHD, with colours representingdifferent clusters. Spatial distribut…
biologicsimmunomodulatorsCrohn’s diseaseIleocolonic diseasetertiary care centreTerminal ileal diseaseEENCerner Millennium
…ires escalation to combination therapy with immunomodulators or biologics, reflecting the high-risk cohort in this centre. The CRP and ES…
TauroLockshort bowel syndromegastrointestinal motility disordersimmune-haem-oncological disordersintestinal mucosal diseasesCRBSI
…y vulnerability, gender, the use of gloves during CVC care, and TauroLock use were not associated with changes in infection rates in this…
SMOFlipofundin lipidIFALDIntestinal Failure Associated Liver DiseaseIntestinal failure-associated liver disease
… predominantly used lipofundin lipid whereas the new group used SMOF which is more liver protective. Hepatoprotective measures such …